Updates

BIG PHARMA WATCH: ANTI-COMPETITIVE CHARITY SCHEMES TAKE CENTER STAGE AT WAYS & MEANS HEARING

Feb 6, 2020

Testimony Highlights How Brand Name Drug Companies Use Nonprofits To Keep Read More

DOSE OF REALITY: BIG PHARMA’S INSULIN PRICE PREDICAMENT

Feb 4, 2020

Pharmaceutical Companies to Blame for Out-of-Control Prices for Life-Saving Read More

CSRxP LAUNCHES SEVEN-FIGURE “PROMISE” CAMPAIGN URGING CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE

Feb 4, 2020

Comprehensive Effort Will Target D.C., In Addition To Nine Presidential & Read More

BIG PHARMA WATCH: BRAND NAME DRUG COMPANIES SHAMELESSLY SKIRT STATE TRANSPARENCY LAWS

Feb 3, 2020

Congressional Action Needed to Shine a Light on Big Pharma’s Egregious Read More

CSRxP: SOTU 2020 OFFERS PRESIDENT UNIQUE MOMENT TO LEAD ON LOWERING Rx PRICES

Feb 3, 2020

Trump Can Use Platform To Demand Congress Hold Big Pharma Accountable & Read More

BIG PHARMA EARNINGS WATCH: AMGEN

Jan 31, 2020

Brand Name Drug Giant Beats Wall Street Expectations After Price Hikes on Read More

BIG PHARMA EARNINGS WATCH: ELI LILLY, ROCHE NOVARTIS & PFIZER

Jan 30, 2020

Brand Name Giants Keep Good Times Rolling Thanks to Series of Price Hikes on Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Jan 23, 2020

Prescription Drug Price Hikes Help Fuel Massive 32 Percent Boost to Profits Read More

CSRXP APPLAUDS SENATE PASSAGE OF USMCA THAT PUTS AMERICAN PATIENTS FIRST

Jan 16, 2020

Lawmakers Hold Strong, Advance Trade Deal Without Big Pharma-Backed Provision Read More

WHAT THEY ARE SAYING: LOWERING Rx PRICES & HOLDING BIG PHARMA ACCOUNTABLE TOP PRIORITY IN 2020

Jan 14, 2020

Editorial Boards, Lawmakers and More Reiterate Need for Market-Based Solutions Read More

BIG PHARMA WATCH: HEADLINES FROM BIG PHARMA’S 2020 PRICE HIKE BONANZA

Jan 13, 2020

News from First Weeks of New Year Underscores Urgent Need for Action in Read More

CSRXP: BIG PHARMA THUMBS ITS NOSE AT STRUGGLING AMERICANS WITH NEW YEAR PRICE HIKES

Jan 2, 2020

Drug Makers, Including Brand Name Giants Like Pfizer, Increase Prices on More Read More